Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma.

Autor: Shinmura, Kohei, Okubo, So, Kadota, Saori, Nakayama, Hitomi, Sakurai, Aki, Kurosawa, Shuhei, Ito, Chisako, Aisa, Yoshinobu, Nakazato, Tomonori
Předmět:
Zdroj: Annals of Hematology; Jan2023, Vol. 102 Issue 1, p223-225, 3p
Abstrakt: Follow-up PET-CT and MRI showed a dramatic reduction of the size of both the median and ulnar nerve tumors (Fig. At 2 years post-CR, the patient developed loss of consciousness, and head magnetic resonance imaging (MRI) revealed a mass in the occipital lobe. Follow-up PET-CT (C) and MRI (D) showed a dramatic reduction of the size of both the median and ulnar nerve tumors Neurolymphomatosis is a rare manifestation of malignant lymphoma that shows selective infiltration to the peripheral nervous system, either primarily or secondarily. [Extracted from the article]
Databáze: Complementary Index
Externí odkaz: